Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

Zanetti SR, Romecin PA, Vinyoles M, Juan M, Fuster JL, Cámos M, Querol S, Delgado M, Menendez P

Open source

DOI
10.1136/jitc-2020-001419
Published
2020 Aug
Container
Journal for immunotherapy of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2020-001419,
  title = {Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.},
  author = {Zanetti SR and Romecin PA and Vinyoles M and Juan M and Fuster JL and Cámos M and Querol S and Delgado M and Menendez P},
  year = {2020},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2020-001419},
  url = {https://doi.org/10.1136/jitc-2020-001419}
}

RIS

TY  - JOUR
TI  - Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.
AU  - Zanetti SR
AU  - Romecin PA
AU  - Vinyoles M
AU  - Juan M
AU  - Fuster JL
AU  - Cámos M
AU  - Querol S
AU  - Delgado M
AU  - Menendez P
PY  - 2020
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2020-001419
UR  - https://doi.org/10.1136/jitc-2020-001419
ER  - 

APA

SR, Z., PA, R., M, V., M, J., JL, F., M, C., S, Q., M, D., & P, M. (2020). Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2020-001419

Source records